SCHEMBL13507908

SCHEMBL13507908

Cn1c2cc(-c3c(-c4ccccc4)ccc4ccccc34)ccc2c2c3ccccc3c3c4ccc(-c5c(-c6ccccc6)ccc6ccccc56)cc4n(C)c3c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 1/20 0.41
▸ MAOB P27338 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.37
▸ HSD11B1 P28845 1/20 0.36
▸ SLC2A1 P11166 1/20 0.35
▸ MAPK14 Q16539 1/20 0.35
▸ RET P07949 2/20 0.35
▸ KDM4E B2RXH2 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ GPR84 Q9NQS5 1/20 0.33
▸ TERT O14746 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13506848 0.91 HSD17B10 (0.38) LIMK1MAOBHSD17B10HSD11B1SLC2A1
SCHEMBL13508616 0.85 LIMK1 (0.32) LIMK1MAOB
SCHEMBL13507978 0.84 LIMK1 (0.44) LIMK1MAOBHSD17B10HSD11B1MAPK14
SCHEMBL13507906 0.83 LIMK1 (0.41) LIMK1MAOBHSD17B10HSD11B1KDM4E
SCHEMBL13507629 0.82 LIMK1 (0.47) LIMK1MAOBHSD17B10HSD11B1KDM4E
SCHEMBL13508164 0.81 LIMK1 (0.39) LIMK1MAOBHSD11B1MAPK14KDM4E
SCHEMBL13507633 0.81 MAOB (0.50) LIMK1MAOBHSD17B10HSD11B1KDM4E
SCHEMBL13507889 0.81 FLT3 (0.37) LIMK1MAOBHSD17B10KDM4EMAPT
SCHEMBL13507867 0.80 MAOB (0.57) LIMK1MAOBHSD17B10KDM4EMAPT
SCHEMBL13507467 0.80 KDM4E (0.40) LIMK1MAOBHSD17B10KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 LIMK1 222/4885MAOB 446/4885HSD17B10 1287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback